MYRIAD GENETICS INC
Ticker: 899923
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 200.40-2.6% | 205.70-3.5% | 213.10+8.8% | 195.90-8.2% | 213.30+0.9% | 211.50+4.6% | 202.20+5.4% | 191.90 |
| Total Income | 200.40-2.6% | 205.70-3.5% | 213.10+8.8% | 195.90-8.2% | 213.30+0.9% | 211.50+4.6% | 202.20+5.4% | 191.90 |
| EXPENSES | ||||||||
| Expenditure | 231.10+0.9% | 229.00-57.8% | 542.30+141.1% | 224.90-3.6% | 233.30-5.9% | 248.00+7.8% | 230.10-8.7% | 252.00 |
| Tax | 0.00-100.0% | 1.20+1300.0% | -0.10+99.7% | -29.30-3355.6% | 0.90+280.0% | -0.50-600.0% | 0.10+0.0% | 0.10 |
| PROFIT | ||||||||
| PBT | -34.10-30.2% | -26.20+92.1% | -330.60-1024.5% | -29.40-38.7% | -21.20+43.0% | -37.20-43.6% | -25.90+57.7% | -61.20 |
| Net Profit | -34.10-24.5% | -27.40+91.7% | -330.50-330400.0% | -0.10+99.5% | -22.10+39.8% | -36.70-41.2% | -26.00+57.6% | -61.30 |
| KEY METRICS | ||||||||
| OPM % | -15.32%-3.99pp | -11.33%+88.67pp | -100.00%-85.20pp | -14.80%-5.43pp | -9.38%+7.88pp | -17.26%-3.46pp | -13.80%+17.52pp | -31.32% |
| NPM % | -17.02%-3.70pp | -13.32%+86.68pp | -100.00%-99.95pp | -0.05%+10.31pp | -10.36%+6.99pp | -17.35%-4.49pp | -12.86%+19.09pp | -31.94% |
| EPS | -0.36-24.1% | -0.29+91.9% | -3.57 | 0.00+100.0% | -0.24+41.5% | -0.41-41.4% | -0.29+61.3% | -0.75 |
Corporate Events
Board MeetingMYGN
202617Jun
Board Meeting
Director Resignation — Daniel M. Skovronsky M.D., Ph.D. resi…
SEC Filing ↗ Board MeetingMYGN
20264Jun
Board Meeting
Myriad Genetics Inc. held its 2026 Annual Meeting of Stockho…
SEC Filing ↗ Board MeetingMYGN
20261Jun
Board Meeting
CTO Appointment — Raj Jampa appointed as Chief Technology Of…
SEC Filing ↗